Lupin Recommends ₹12 Final Dividend for FY25; Record Date Set for July 25

Pharmaceutical major Lupin Limited has drawn attention after announcing a final dividend for the financial year ended March 31, 2025. The announcement was made earlier, but the company reiterated the key dates and details on July 14, 2025.

Dividend Recommendation Details

At its Board meeting held on May 14, 2025, Lupin’s directors recommended a final dividend of ₹12 per equity share of ₹2 each. This amounts to a 600% dividend payout for FY25, subject to shareholder approval at the upcoming Annual General Meeting (AGM).

Record Date and Eligibility

The company has fixed Friday, July 25, 2025, as the record date for determining the eligibility of shareholders entitled to receive the final dividend.

Shareholders whose names appear in the Register of Members or the records of the Depositories (NSDL/ CDSL) as beneficial owners on this date will be eligible for the dividend payout.

Payment Timeline and Taxation

The dividend, if approved at Lupin’s AGM scheduled for Monday, August 11, 2025, will be disbursed within 30 days of the declaration. The payout will be made after deducting applicable taxes at source, in line with current income tax regulations.

Lupin Share Price Performance

On July 15, 2025, Lupin share price opened at ₹1,931.00, up from its previous close of ₹1,926.10. At 9:50 AM, the share price of Lupin was trading at ₹1,923.90, down by 0.11% on the NSE.

Also Read: Best Pharma Stocks in July 2025!

Conclusion

After Lupin’s dividend proposal, investors are now watching the upcoming AGM, which will finalise the approval and timeline of the dividend payout.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.

Investments in the securities market are subject to market risks, read all the related documents carefully before investing.